Search

Your search keyword '"Alaoui-Jamali, Moulay A."' showing total 528 results

Search Constraints

Start Over You searched for: Author "Alaoui-Jamali, Moulay A." Remove constraint Author: "Alaoui-Jamali, Moulay A."
528 results on '"Alaoui-Jamali, Moulay A."'

Search Results

1. Corrigendum

4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

5. Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

6. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

7. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer

10. Supplementary Data from MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

11. Data from MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

14. Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.

15. RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells

16. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis

22. Data from A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

23. Supplementary Data S18 from A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

24. Supplementary Data - Tables S1-S17 from A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

27. Suppl Figure 1-6, Suppl Table S0 and Suppl Methods from A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

30. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

33. Data from MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

36. Supplementary Data from MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

37. Supplementary Figure 1 from A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer

39. Supplementary Figure 4 from A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer

40. Supplementary Figure 3 from A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer

41. Supplementary Figure 2 from A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer

42. Supplementary Methods, Figure Legends 1-4 from A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate Cancer

44. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer

45. Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV600E-Positive Papillary Thyroid Cancer

Catalog

Books, media, physical & digital resources